Response to "Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes".
Conesa-Botella
A
A
Colebunders
R
R
D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5 / Q000235:genetics; D000075202:Contraindications; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019713:Receptors, CCR5 / Q000235:genetics; D014195:Travel; D014766:Viremia; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000009:adverse effects*
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5; D019713:Receptors, CCR5; D022341:Yellow Fever Vaccine